TCT · San Diego · 2026-10-31 – 2026-11-03
TCT 2026
0 de 28 ensaios Late-Breaking com resultadoOs resultados estão sob embargo até cada apresentação e surgem aqui assim que são divulgados.
sáb., 31 de out.
dom., 1 de nov.
Late-Breaking Clinical Trials: Session I, in Collaboration with The Lancet
10:45–12:13 (America/Los_Angeles) · Main Arena · Hall H- 10:45P4Estudo clínico · Carlos ColletCoronary CT Angiography-Guided vs. IVUS-Guided PCI: The Randomized P4 TrialApresentado — resultado a seguir
- 11:07TRANSFORM IIEstudo clínico · Bernardo CorteseSirolimus Coated Balloons vs. Drug-eluting Stents in Native Coronary Vessels: The TRANSFORM II Randomized TrialApresentado — resultado a seguir
- 11:29HD-PCIEstudo clínico · Sanjit S. JollyA Randomized Trial of Higher vs. Lower Dose Heparin for PCI: The HD-PCI TrialApresentado — resultado a seguir
- 11:51REMEDY-PILOTEstudo clínico · Kevin ChengCoronary Sinus Reducer for Refractory Angina in ANOCA: A Randomized Double-Blind Sham-Controlled Trial (REMEDY-PILOT)Apresentado — resultado a seguir
Late-Breaking Clinical Science: Session I, in Collaboration with Circulation
14:15–15:45 (America/Los_Angeles) · Main Arena · Hall H- 14:15VERITASEstudo clínico · Dhanunjaya LakkireddyOne-Year Outcomes with the Amulet 360 Device for Left Atrial Appendage Closure: The VERITAS Amulet 360 StudyApresentado — resultado a seguir
- 14:33Community TR cohortEstudo observacional · Rebecca T. HahnCharacteristics and Clinical Outcomes of Tricuspid Regurgitation in the Community: Insights from a Real-World Cohort of 180,977 Men and WomenApresentado — resultado a seguir
- 14:51TRAVEL IIIEstudo clínico · Junbo GeTranscatheter Tricuspid Valve Replacement with the LuX-Valve Plus System vs. Medical Therapy for Severe TR: The Randomized TRAVEL III TrialApresentado — resultado a seguir
- 15:09TRIC-I-HF subgroupsEstudo observacional · Jörg HausleiterTranscatheter Tricuspid Valve Intervention in Heart Failure: Key Subgroup Results from the TRIC-I-HF-DZHK24 TrialApresentado — resultado a seguir
- 15:27EARLY TAVR economicsEstudo observacional · Neel ButalaEconomic Outcomes and Cost-Effectiveness of TAVR for Asymptomatic Severe Aortic Stenosis: Results from the EARLY TAVR TrialApresentado — resultado a seguir
seg., 2 de nov.
Late-Breaking Clinical Trials: Session II, in Collaboration with the New England Journal of Medicine
09:40–11:10 (America/Los_Angeles) · Main Arena · Hall H- 09:40PROGRESSEstudo clínico · Philippe GenereuxTAVR or Clinical Surveillance for Moderate Aortic Stenosis: Primary Results of the PROGRESS Randomized TrialApresentado — resultado a seguir
- 10:04GBD degenerative mitral valve diseaseEstudo observacional · Juan F. GranadaGlobal Burden and Outcomes of Degenerative Mitral Valve Disease: A 30-Year Analysis of the Global Burden of Disease StudyApresentado — resultado a seguir
- 10:25CLASP II TREstudo clínico · Suzanne V. Arnold, Charles J. DavidsonTranscatheter Tricuspid Valve Repair with the PASCAL System vs. Medical Therapy for Severe, Symptomatic Tricuspid Regurgitation: Clinical and Health Status Outcomes from the CLASP II TR Randomized TrialApresentado — resultado a seguir
- 10:49SIMPLAAFYEstudo clínico · Saibal KarAntithrombotic Monotherapy After Left Atrial Appendage Occlusion: Primary Results of the SIMPLAAFY Randomized TrialApresentado — resultado a seguir
Late-Breaking Clinical Science: Session II, in Collaboration with the European Heart Journal
14:15–15:45 (America/Los_Angeles) · Main Arena · Hall H- 14:15PeriSorbEstudo clínico · Yuan CheOne-Year Outcomes of the PeriSorb Bioresorbable Vascular Scaffold vs. Drug-Coated Balloon for Superficial Femoral Artery Disease: A Multicenter Randomized TrialApresentado — resultado a seguir
- 14:33SIRONAEstudo clínico · Ulf TeichgräberThree-Year Outcomes of Sirolimus vs. Paclitaxel-Coated Balloons for Femoropopliteal Artery Disease: The Randomized SIRONA TrialApresentado — resultado a seguir
- 14:51AIR STEMI non-culprit severityEstudo observacional · Simone BiscagliaImpact of Non-Culprit Lesion Severity on the Utility of Functional Coronary Angiography in Patients with STEMI and Multivessel Disease: The AIR STEMI Randomized TrialApresentado — resultado a seguir
- 15:09LIPSIA-STRATEGYEstudo clínico · Nicolas MajunkeAngiography-Derived FFR Versus vs. Wire-Based FFR to Guide Coronary Revascularization: The LIPSIA-STRATEGY TrialApresentação seg., 15:09
- 15:27Nicorandil no-reflow trialEstudo clínico · Takashi MuramatsuIntracoronary Delivery of Nicorandil for Prevention of No-Reflow in Patients Undergoing Primary PCI for STEMI: A Multicenter Randomized TrialApresentação seg., 15:27
ter., 3 de nov.
Late-Breaking Clinical Trials: Session III, in Collaboration with the Journal of the American College of Cardiology
10:45–12:15 (America/Los_Angeles) · Main Arena · Hall H- 10:45PIONEER IVEstudo clínico · Patrick W. SerruysAngiography-Derived FFR vs. Usual Care for Lesion Selection and Optimization in All-Comers PCI: Final Results of the PIONEER IV Randomized TrialApresentação ter., 10:45
- 11:03EPIC17-VERONICAEstudo clínico · Iñigo LozanoPlatelet Function Testing to Guide P2Y12 Inhibitor De-Escalation After ACS: The EPIC17-VERONICA Randomized TrialApresentação ter., 11:03
- 11:21SPYRAL AFFIRMEstudo clínico · David E. KandzariSafety and Effectiveness of Radiofrequency Renal Denervation in the United States: Primary Results of the SPYRAL AFFIRM Post-Approval StudyApresentação ter., 11:21
- 11:39SINGLE-CLOSUREEstudo clínico · Jun JiangSingle vs. Double ProGlide Devices for Access Site Closure After Transfemoral TAVR: The SINGLE-CLOSURE TrialApresentação ter., 11:39
- 11:57IRIS-MAINEstudo observacional · Duk-Woo ParkLong-Term Survival after Coronary Revascularization for Unprotected Left Main Disease (the IRIS-MAIN Registry): A Prospective, Multicenter, Multinational Cohort StudyApresentação ter., 11:57
Late-Breaking Clinical Science: Session III, in Collaboration with the Journal of the American Medical Association
12:20–13:50 (America/Los_Angeles) · Main Arena · Hall H- 12:20ENCIRCLEEstudo clínico · John G. WebbPercutaneous Transcatheter Mitral Valve Replacement in Patients with Symptomatic Mitral Regurgitation: 2-Year Outcomes from the ENCIRCLE TrialApresentação ter., 12:20
- 12:38PROTEMBOEstudo clínico · Susheel K. KodaliThe ProtEmbo® Cerebral Protection System During TAVR: Final Results of the Randomized PROTEMBO IDE TrialApresentação ter., 12:38
- 12:56JENA-VADEstudo clínico · Torsten P. VahlTranscatheter Aortic Valve Replacement with the JenaValve Trilogy System for Aortic Regurgitation in Patients with a Left Ventricular Assist Device: The JENA-VAD StudyApresentação ter., 12:56
- 13:14DUOTAPEstudo clínico · Maximilian AutherithRoutine Post-Dilation vs. Conventional Deployment for Balloon-Expandable TAVR: The Randomized DUOTAP TrialApresentação ter., 13:14
- 13:32TAVR vs SAVR for aortic regurgitationEstudo clínico · YAOFU ZHENGTranscatheter vs. Surgical AVR for Symptomatic, Severe Aortic Regurgitation: One-Year Outcomes from a Multicenter Randomized TrialApresentação ter., 13:32